AGM Details

The 18th AGM of Supriya Lifescience Limited will be held on Thursday, September 24, 2026 at 03:00 PM (IST) through Video Conferencing/Other Audio Visual Means in compliance with Ministry of Corporate Affairs and SEBI circulars.

Business to be Transacted

ORDINARY BUSINESS:

1. To receive, consider, approve and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2026, and the reports of the Board of Directors and Auditors thereon.

2. To declare a Final Dividend of ₹1.00 (50%) per Equity Share of ₹2 for the Financial Year ended March 31, 2026.

3. To appoint directors in place of Dr. Saloni Satish Wagh (DIN: 08491410) and Ms. Shivani Satish Wagh (DIN: 08491420) who retire by rotation under Section 152(6) of the Companies Act, 2013.

SPECIAL BUSINESS:

4. To ratify the remuneration of Cost Auditors for FY 2026-27 - ₹2,50,000 (Rupees Two Lakhs Fifty Thousand only) plus applicable tax and out-of-pocket expenses payable to M/s. Rampurawala Mohammed A & Co, Cost Accountants (Firm Registration No. 003011).

Dividend Information

  • Record Date for final dividend: Friday, September 4, 2026
  • Dividend payment timeline: On or after Thursday, September 24, 2026 (if approved)
  • TDS will be applicable as per Income Tax Act, 2025 provisions
  • Dividend will be subject to deduction of tax at source

Director Re-appointment Details

Dr. Saloni Satish Wagh (DIN: 08491410)

  • Date of Birth: June 22, 1990 (Age: 36 years)
  • First Appointment: July 1, 2019
  • Qualification: Ph.D. in Chemistry & Master's degree in Science
  • Current Position: Managing Director (since August 1, 2024)
  • Responsibilities: Export, Marketing & Business Development, overall management
  • Shareholding: 102,375 shares (0.13%)
  • Committee Memberships: Stakeholders' Relationship Committee, Risk Management Committee, Corporate Social Responsibility Committee
  • Board Meetings Attended (FY 2025-26): 4 out of 4

Ms. Shivani Satish Wagh (DIN: 08491420)

  • Date of Birth: September 27, 1991 (Age: 34 years)
  • First Appointment: July 1, 2019
  • Qualification: Masters in Management Studies, Master's in International Business Management
  • Current Position: Joint Managing Director (since August 1, 2024)
  • Responsibilities: Exports (Europe), Marketing & Business Development, overall management
  • Shareholding: 102,375 shares (0.13%)
  • Committee Memberships: None
  • Board Meetings Attended (FY 2025-26): 4 out of 4

Voting Information

  • Remote e-voting period: September 21, 2026 (9:00 AM) to September 23, 2026 (5:00 PM)
  • Cut-off date for voting rights: September 4, 2026
  • NSDL appointed as authorized agency for e-voting facilities
  • Scrutinizer: Mr. Sanam Umbargikar (M.No. 11777, CP No. 9394) of M/s. DSM & Associates

Document Availability

  • Annual Report and AGM Notice available on company website: www.supriyalifescience.com
  • Also available on BSE (www.bseindia.com) and NSE (www.nseindia.com) websites
  • Available on NSDL e-voting portal: https://www.evoting.nsdl.com

Additional Information

  • No shares in Unclaimed Suspense Account
  • AGM conducted through VC/OAVM without physical presence
  • Facility for 1000 members on first-come-first-served basis (exceptions for large shareholders, promoters, etc.)
  • Members can inspect documents electronically by emailing cs@supriyalifescience.com

Tax Implications

Detailed TDS provisions explained for:

  • Resident individual shareholders (10% TDS if dividend exceeds ₹10,000)
  • Resident non-individual shareholders (10% TDS)
  • Non-resident shareholders including FPIs/FIIs (20% plus surcharge and cess)
  • Procedures for lower TDS certificates and DTAA benefits outlined

Corporate Office

207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai - 400 063

Factory Address

A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.- Khed, Dist. - Ratnagiri, Pin: 415 722, Maharashtra